Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - February 2014


Generics and Biologics 2014

24 Feb 2014 - 25 Feb 2014 - Mumbai, India



Bookmark and Share


The past decade has witnessed significant consolidation in the generic industry mostly because of patent expiry of large number of pharmaceutical innovator products. Given the tremendous pressure on both innovator and generic companies to maintain growth, this trend is likely to continue. This growth has also brought in stern competition amongst generic pharmaceutical companies in order to get a slice of pie out of the market. Innovation strategies, niche generics, cost reduction and reducing regulatory uncertainties are some of the topics to be deliberated for the success of the generic pharmaceutical industry. The Generics track of this event aims to bring together the experience of Pharmaceutical Industry professionals for achieving this objective.

Quality and structure of biologics is of utmost importance because of their dependency on extremely narrow specifications in manufacturing processes. This track on Biologics will focus on development of quality biologics on one hand and regulatory requirements and compliance issues, as well as expedited approval and market introduction of biosimilar competitors on the other hand.  Biosimilars or follow-on-biologics or subsequent entry biologics provide potential cost saving opportunities for drug manufacturers and therefore will be in the spotlight. 

This event is co-located with our 2nd international event on “QbD in Pharma Development” and an exhibition featuring latest technology and equipment in formulation development, bioanalysis and software for QbD studies. Registered delegates will have unrestricted access to all the co-located events and exhibition.

Agenda Tracks:
•    Generics - Expanding the Base: Improving Business and Regulatory Predictability for Complex, Niche Generics
•    Biologics - Quality Biologics for Ensuring Regulatory and Market Success

Call for Posters
You can also present your research on a poster while attending the meeting. Submit an abstract for consideration now!
Poster Submission Deadline: 19 January 2014



Further information
Scientific News
Envigo Rat Models Proven to be Susceptible to Intra-Vaginal HSV-2 Infection and Protectable
Scientific findings establish the effectiveness of new approach to investigate the protective effects of vaccine candidates and anti-viral microbodies and to study asymptomatic primary genital HSV-2 infection.
Drug that Activates Innate Immune System Identified
Researchers from the institute have identified a drug, which is straightforward to synthesize and to couple to antigens that induce an immune response and may prove useful in the generation of vaccines.
Valvena, GSK Sign New R&D Collaboration
Valneva to supply process development services for EB66® -based Influenza vaccines.
Counting Cancer-busting Oxygen Molecules
Researchers from the Centre for Nanoscale BioPhotonics (CNBP), an Australian Research Centre of Excellence, have shown that nanoparticles used in combination with X-rays, are a viable method for killing cancer cells deep within the living body.
Therapeutic Approach Gives Hope for Multiple Myeloma
A new therapeutic approach tested by a team from Maisonneuve-Rosemont Hospital (CIUSSS-EST, Montreal) and the University of Montreal gives promising results for the treatment of multiple myeloma, a cancer of the bone marrow currently considered incurable with conventional chemotherapy and for which the average life expectancy is about 6 or 7 years.
Protein Protects Against Flu in Mice
The engineered molecule doesn’t provoke inflammation and may hail a new class of antivirals.
Crowdfunding the Fight Against Cancer
From budding social causes to groundbreaking businesses to the next big band, crowdfunding has helped connect countless worthy projects with like-minded people willing to support their efforts, even in small ways. But could crowdfunding help fight cancer?
Natural Protein Points to New Inflammation Treatment
Findings may offer insight to effective treatments for inflammatory diseases, such as rheumatoid arthritis, psoriasis, and multiple sclerosis.
Tricked-Out Immune Cells Could Attack Cancer
New cell-engineering technique may lead to precision immunotherapies.
Therapy Halts Progression of Lou Gehrig’s Disease
Researchers at Oregon State University announced today that they have essentially stopped the progression of amyotrophic lateral sclerosis (ALS), or Lou Gehrig’s disease, for nearly two years in one type of mouse model used to study the disease – allowing the mice to approach their normal lifespan.
Scroll Up
Scroll Down
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!